Literature DB >> 14512165

Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice.

Andleeb Zameer1, Steven A Hoffman.   

Abstract

Pathogenic mechanisms of central nervous system (CNS) involvement in systemic lupus erythematosus (SLE) remain unknown. We recently reported the presence of autoantibodies in the brain tissue ex vivo of autoimmune MRL/lpr mice. We postulated that at least some of these autoantibodies are produced in situ because of B-cell entry into the brain. The blood-brain barrier (BBB) blocks the entry of most large molecules and cells into the brain. In certain CNS pathologies, however, immune cells gain entry due to elevated expression of adhesion molecules. This study looked at adhesion molecule expression, ICAM-1 and VCAM-1, in the brains of MRL/lpr mice. Using immunofluorescent antibody binding assays and confocal laser imaging, we show that expression of ICAM-1 and VCAM-1 is elevated in MRL/lpr mice brains at 4 months of age as compared to age-matched controls. These results suggest a possible mechanism for leukocyte entry into the brains of autoimmune mice that in turn suggest immune-mediated pathology in CNS-lupus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512165     DOI: 10.1016/s0165-5728(03)00262-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

Review 1.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

Review 2.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

Review 3.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

Review 4.  The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface.

Authors:  Ariel D Stock; Sivan Gelb; Ofer Pasternak; Ayal Ben-Zvi; Chaim Putterman
Journal:  Autoimmun Rev       Date:  2017-04-17       Impact factor: 9.754

5.  Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Authors:  Boris Sakic; David L Kirkham; David A Ballok; James Mwanjewe; Ian M Fearon; Joseph Macri; Guanhua Yu; Michelle M Sidor; Judah A Denburg; Henry Szechtman; Jonathan Lau; Alexander K Ball; Laurie C Doering
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

6.  Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain.

Authors:  J D Huber; C R Campos; K S Mark; T P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-30       Impact factor: 4.733

7.  Neuroimmune aspects of the pathogenesis of Tourette's syndrome and experience in the use of immunoglobulins in children.

Authors:  V P Zykov; A Yu Shcherbina; E B Novikova; T V Shvabrina
Journal:  Neurosci Behav Physiol       Date:  2009-09

8.  Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice.

Authors:  M Ursula Norman; Will G James; Michael J Hickey
Journal:  J Leukoc Biol       Date:  2008-04-21       Impact factor: 4.962

9.  C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus.

Authors:  Supriya D Mahajan; Neil U Parikh; Trent M Woodruff; James N Jarvis; Molly Lopez; Teresa Hennon; Patrick Cunningham; Richard J Quigg; Stanley A Schwartz; Jessy J Alexander
Journal:  Immunology       Date:  2015-07-15       Impact factor: 7.397

10.  Effects of prolonged treatment with memantine in the MRL model of CNS lupus.

Authors:  Katarina Marcinko; Tiffany Parsons; Jason P Lerch; John G Sled; Boris Sakic
Journal:  Clin Exp Neuroimmunol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.